Singapore markets close in 44 minutes

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.08-0.31 (-2.32%)
At close: 04:00PM EDT
13.40 +0.32 (+2.45%)
After hours: 07:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close13.39
Bid0.00 x 1000
Ask0.00 x 800
Day's range12.96 - 13.49
52-week range5.60 - 19.32
Avg. volume1,105,020
Market cap1.017B
Beta (5Y monthly)1.18
PE ratio (TTM)N/A
EPS (TTM)-2.75
Earnings date07 Nov 2022 - 11 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est20.00
  • Motley Fool

    Coherus BioSciences (CHRS) Q2 2022 Earnings Call Transcript

    This release can be found on the Coherus BioSciences website and is also attached to our Form 8-K. Today's call includes forward-looking statements regarding Coherus' current expectations about future events. All these forward-looking statements involve substantial risks and uncertainties that are beyond our control and could cause actual results, performance or achievements to differ from results, performance or achievements implied by the forward-looking statements.

  • Zacks

    Coherus BioSciences (CHRS) Reports Q2 Loss, Tops Revenue Estimates

    Coherus BioSciences (CHRS) delivered earnings and revenue surprises of 32.29% and 3.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Zacks

    Wall Street Analysts Predict an 85% Upside in Coherus BioSciences (CHRS): Here's What You Should Know

    The consensus price target hints at an 84.6% upside potential for Coherus BioSciences (CHRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.